Randomized comparison of cooked and noncooked diets in patients undergoing remission induction therapy for acute myeloid leukemia
- PMID: 18955453
- PMCID: PMC4879706
- DOI: 10.1200/JCO.2008.16.4681
Randomized comparison of cooked and noncooked diets in patients undergoing remission induction therapy for acute myeloid leukemia
Abstract
Purpose: A neutropenic diet is often used to prevent infection in patients with acute myeloid leukemia (AML). Although such a diet potentially entails inconvenience, its value is uncertain.
Patients and methods: One hundred fifty-three patients admitted to a high-efficiency particulate air-filtered room (protected environment [PE]) to receive induction therapy for newly diagnosed AML were randomly assigned to a diet containing no raw fruits or vegetables (cooked diet) or to a diet containing fresh fruit and fresh vegetables (raw diet). Stratification was based on the patients' early risk of mortality (ERM) score. All patients received antibacterial and antifungal prophylaxis and remained on study until they were discharged from the PE. The outcomes of principal interest were major infection (pneumonia, bacteremia, or fungemia) and death; if the true probability of either event was 20% on the cooked arm and 40% on the raw arm, then the probability that the cooked arm would be selected as superior was 83%.
Results: Seventy-eight patients were randomly assigned to the cooked arm, and 75 were assigned to the raw arm. The two groups were similar with respect to age, ERM, chemotherapy received, and days at risk. Twenty-nine percent of patients in the cooked group and 35% of patients in the raw group developed a major infection (P = .60). Time to major infection and survival time were similar in the two groups. Fever of unknown origin occurred in 51% of the cooked group and 36% of the raw group.
Conclusion: In patients treated in a PE, a neutropenic diet did not prevent major infection or death.
Figures
Similar articles
-
Lack of Effectiveness of Neutropenic Diet and Social Restrictions as Anti-Infective Measures in Children With Acute Myeloid Leukemia: An Analysis of the AML-BFM 2004 Trial.J Clin Oncol. 2016 Aug 10;34(23):2776-83. doi: 10.1200/JCO.2016.66.7881. Epub 2016 Jun 6. J Clin Oncol. 2016. PMID: 27269945 Free PMC article. Clinical Trial.
-
Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.Cancer. 2003 Jan 15;97(2):450-6. doi: 10.1002/cncr.11094. Cancer. 2003. PMID: 12518369 Clinical Trial.
-
Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy.Cancer. 2004 Feb 1;100(3):581-9. doi: 10.1002/cncr.11936. Cancer. 2004. PMID: 14745876 Clinical Trial.
-
Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission.Cochrane Database Syst Rev. 2015 Nov 6;2015(11):CD010248. doi: 10.1002/14651858.CD010248.pub2. Cochrane Database Syst Rev. 2015. PMID: 26544114 Free PMC article. Review.
-
The neutropenic diet reviewed: moving toward a safe food handling approach.Oncology (Williston Park). 2012 Jun;26(6):572-5, 580, 582 passim. Oncology (Williston Park). 2012. PMID: 22870542 Review.
Cited by
-
The neutropenic diet and its impacts on clinical, nutritional, and lifestyle outcomes for people with cancer: a scoping review.J Nutr Sci. 2024 Oct 10;13:e60. doi: 10.1017/jns.2024.61. eCollection 2024. J Nutr Sci. 2024. PMID: 39469195 Free PMC article. Review.
-
Pathogen detection by targeted next-generation sequencing test in adult hematological malignancies patients with suspected infections.Front Med (Lausanne). 2024 Sep 24;11:1443596. doi: 10.3389/fmed.2024.1443596. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39380735 Free PMC article.
-
Successful Management of Neutropenic Sepsis Is Key to Better Survival of Patients With Blood Cancer in Sri Lanka: Real-World Data From the Resource-Limited Setting.JCO Glob Oncol. 2024 Mar;10:e2300412. doi: 10.1200/GO.23.00412. JCO Glob Oncol. 2024. PMID: 38484192 Free PMC article.
-
Nonrestrictive diet does not increase infections during post-HSCT neutropenia: data from a multicenter randomized trial.Blood Adv. 2023 Oct 10;7(19):5996-6004. doi: 10.1182/bloodadvances.2023010348. Blood Adv. 2023. PMID: 37450382 Free PMC article.
-
Vitamin C deficiency in patients with acute myeloid leukemia: a case series and review of the literature.Blood Adv. 2023 Oct 10;7(19):5780-5783. doi: 10.1182/bloodadvances.2023009923. Blood Adv. 2023. PMID: 37433638 Free PMC article. Review. No abstract available.
References
-
- Bodey GP, Buckley M, Sathe YS, et al: Quantitative relationship between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64:328-340, 1966 - PubMed
-
- Smith LH, Besser SG: Dietary restrictions for patients with neutropenia: A survey of institutional practices. Oncol Nurs Forum 27:515-520, 2000 - PubMed
-
- Wilson BJ: Dietary recommendations for neutropenic patients. Semin Oncol Nurs 18:44-49, 2002 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
